Home|Journals|Articles by Year|Audio Abstracts

Case Report

EJMCR. 2022; 6(3): 48-51

Toxic pneumonitis induced by trastuzumab as a potentially fatal event: a case report

Raquel Fontes, Jorge Rodrigues, Camila Oliveira, Mauricio Peixoto, Ricardo Fernandes, Luisa Queiroz, Catarina Portela, Marta Almeida, Rui Nabico.

Cited by 0 Articles

Background: Trastuzumab is a widely used and well-tolerated drug. Pulmonary toxicity has been described; however, the low incidence, the variability at presentation, and the nonspecific characteristics often make it an exclusion diagnosis.
Case presentation: We present the case of a 62-year-old women admitted to our service with fever and shortness of breast after treatment with trastuzumab. From the study performed, no other cause was found to explain the event and the patient kept worsening until the diagnosis was established.
Conclusion: Although pneumonitis is a rare side effect of trastuzumab administration, early recognition and appropriate therapy are crucial and may be lifesaving.

Key words: breast cancer; trastuzumab; adverse reactions; pulmonary toxicity; case report

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.